This new drug could break cancer’s resistance to treatment
Tuesday, September 22, 2026Want headlines delivered to your inbox?
Subscribe to our free daily newsletter.
A new experimental drug called CS18 may help break through cancer drug resistance by disabling several of the defenses tumors use to survive treatment. It strengthened existing therapies, restored drug sensitivity in resistant lung cancer cells, and slowed tumor growth in animal models. (via Science Daily)
Read the Full StoryThis article will expire in 28 days.
In the News...
View All Recent News
- Rare pregnancy infections may triple the risk of autism
- Breakthrough drug reverses skin aging and dramatically speeds healing
- GLP-1 weight loss and diabetes drugs linked to nutritional deficiencies in nearly 1 in 6 children
- More REM sleep linked to lower risk of 83 diseases
- This new drug could break cancer’s resistance to treatment
- Coffee doesn’t have to keep you awake to disrupt your sleep
- This emerging treatment could help people avoid knee replacement surgery
- Brain scans reveal a possible cause of long COVID fatigue and brain fog
- Stopping Ozempic may raise heart attack and stroke risk
- Stem cells reverse stroke damage and restore movement in mice
- Stanford scientists discover the human brain may actually be two separate organs
- Chronic stress may be quietly reshaping your heart
- Scientists create a needle-thin brain implant that can do three jobs at once
- Millions take calcium and vitamin D for bone health. A major review finds little benefit
- Ancient DNA reveals how plague kept returning for 400 years after the Black Death
- 8 common food additives linked to high blood pressure and heart disease
- Hidden gut defect that may explain why IBD keeps coming back
- Scientists solve a 50-year mystery and discover a new human blood group
- Scientists find that “perfect” systems may be surprisingly fragile
- A deadly ebola relative is surging after years in the shadows